{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:54:38Z","timestamp":1791644078728,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1124\/mol.63.6.1223","type":"journal-article","created":{"date-parts":[[2003,5,22]],"date-time":"2003-05-22T02:58:01Z","timestamp":1053572281000},"page":"1223-1229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":268,"title":["3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro"],"prefix":"10.1016","volume":"63","author":[{"given":"Vincent","family":"Setola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra J.","family":"Hufeisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Jane","family":"Grande-Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Glennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.63.6.1223_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.63.6.1223_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1749-6632.2000.tb05194.x","article-title":"Serotonin transporters, serotonin release and the mechanism of fenfluramine neurotoxicity","volume":"914","author":"Baumann","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/mol.63.6.1223_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluraminephentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.63.6.1223_bib4","first-page":"1736","article-title":"Ergotamine-induced heart valve fibrosis and coronary microangiopathy?","volume":"117","author":"Creutzig","year":"1992","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1124\/mol.63.6.1223_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2125.2000.00121.x","article-title":"Non-linear pharmacokinetics of MDMA (\u2018ecstasy\u2019) in humans","volume":"49","author":"de la Torre","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/mol.63.6.1223_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.6.1223_bib7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.63.6.1223_bib8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/nm764","article-title":"Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension","volume":"8","author":"Launay","year":"2002","journal-title":"Nat Med"},{"key":"10.1124\/mol.63.6.1223_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0304-3940(94)90057-4","article-title":"Effect of the R(-) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors","volume":"177","author":"Nash","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1124\/mol.63.6.1223_bib10","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1073\/pnas.97.17.9508","article-title":"Serotonin 2B receptor is required for heart development","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.63.6.1223_bib11","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.050282397","article-title":"5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways","volume":"97","author":"Nebigil","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.63.6.1223_bib12","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4065\/77.12.1280","article-title":"Valvular heart disease in patients taking pergolide","volume":"77","author":"Pritchett","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1124\/mol.63.6.1223_bib13","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1073\/pnas.182234399","article-title":"Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist","volume":"99","author":"Roth","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.63.6.1223_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0163-7258(02)00234-6","article-title":"Therapeutic and adverse actions of serotonin transporter substrates","volume":"95","author":"Rothman","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.63.6.1223_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3","article-title":"Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin","volume":"39","author":"Rothman","year":"2001","journal-title":"Synapse"},{"key":"10.1124\/mol.63.6.1223_bib16","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1161\/01.CIR.102.23.2836","article-title":"Evidence for possible involvement of 5-HT2B receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications","volume":"102","author":"Rothman","year":"2000","journal-title":"Circulation"},{"key":"10.1124\/mol.63.6.1223_bib17","first-page":"256","article-title":"Expression of 5-hydroxytryptamine receptor subtype messenger RNA in interstitial cells from human heart valves","volume":"9","author":"Roy","year":"2000","journal-title":"J Heart Valve Dis"},{"key":"10.1124\/mol.63.6.1223_bib18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-6147(03)00027-0","article-title":"Salvinorin A: the \u2018magic mint\u2019 hallucinogen finds a molecular target in the kappa opioid receptor","volume":"24","author":"Sheffler","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.63.6.1223_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1054-8807(99)00019-8","article-title":"Histologic changes in three explanted native cardiac valves following use of fenfluramines","volume":"8","author":"Steffee","year":"1999","journal-title":"Cardiovasc Pathol"},{"key":"10.1124\/mol.63.6.1223_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000441-200104000-00008","article-title":"Appetite suppressants and valvular heart disease","volume":"321","author":"Weissman","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1124\/mol.63.6.1223_bib21","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustainedrelease dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.63.6.1223_bib22","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/S0002-9440(10)64497-5","article-title":"Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells","volume":"161","author":"Xu","year":"2002","journal-title":"Am J Pathol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24058413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24058413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.63.6.1223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:56:30Z","timestamp":1740041790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24058413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["S0026895X24058413"],"URL":"https:\/\/doi.org\/10.1124\/mol.63.6.1223","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,4-Methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) Induces Fenfluramine-Like Proliferative Actions on Human Cardiac Valvular Interstitial Cells in Vitro","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.63.6.1223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}